Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6229 USD | -5.38% | -9.54% | +8.75% |
Jul. 08 | HilleVax to discontinue development of norovirus vaccine for infants; shares plummet | RE |
Jun. 14 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
Business Summary
Number of employees: 109
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oral Recombinant Protein Vaccines
100.0
%
| 0 | 100.0 % | 7 | 100.0 % | +6,796.26% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 7 | 100.0 % | +6,796.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sean Tucker
FOU | Founder | 56 | 03-12-31 |
Phillip Eric Lee
DFI | Director of Finance/CFO | 37 | 22-12-18 |
Michael Finney
CHM | Chairman | 65 | 07-06-30 |
James Cummings
CTO | Chief Tech/Sci/R&D Officer | 58 | 21-09-26 |
Chief Tech/Sci/R&D Officer | - | 22-08-30 | |
Edward Berg
LAW | General Counsel | 60 | 22-02-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Yedid
BRD | Director/Board Member | 66 | 19-10-24 |
Elaine Heron
BRD | Director/Board Member | 76 | 22-08-24 |
Michael Finney
CHM | Chairman | 65 | 07-06-30 |
Sean Tucker
FOU | Founder | 56 | 03-12-31 |
David Wheadon
BRD | Director/Board Member | 66 | 21-04-20 |
William Watson
BRD | Director/Board Member | 73 | 22-08-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 177,502,934 | 174,923,456 ( 98.55 %) | 664,923 ( 0.3746 %) | 98.55 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.75% | 149M | |
+18.43% | 122B | |
+19.81% | 112B | |
-23.74% | 19.33B | |
-18.45% | 16.17B | |
-19.97% | 15.6B | |
-49.33% | 14.65B | |
+57.08% | 14.34B | |
+7.95% | 14B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- VXRT Stock
- Company Vaxart, Inc.